SAN FRANCISCO — Two studies presented at the American Diabetes Association Scientific Sessions yield mixed results for the use of approved diabetes therapies for perioperative management of ...

Janumet™ (MK-0431A) combines two OADs with complementary mechanisms of action to improve glycemic control, sitagliptin and metformin. The tablet was designed in order to be bioequivalent to ...

Sitagliptin, an oral glucose-lowering agent, has been found to produce cardiovascular protection possibly via anti-inflammatory and anti-atherosclerotic activities of glucagon-like peptide-1 receptor ...

The long-awaited results, presented Monday at the 75th Scientific Sessions of the American Diabetes Association, are expected to strengthen sitagliptin's position against its competitors in the DPP-4 ...

Discover comprehensive details about Sitagliptin-Metformin, including its pronunciation, uses, dosage instructions, indications, and guidelines on how and when to take it or avoid it. The updated ...

Sitagliptin and glipizide monotherapy is safe and effective in patients with type 2 diabetes and end-stage renal disease (ESRD) requiring dialysis, researchers reported online ahead of print in the ...

Objective: To evaluate attainment of diabetes-related quality measures with canagliflozin, a sodium glucose cotransporter 2 inhibitor, versus sitagliptin in patients with type 2 diabetes mellitus ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The authors acknowledge that the study's design means this finding can't be considered definitive.

Treatment with sitagliptin resulted in increased creatinine-based fractional excretions of sodium (P = .005) and fractional excretions of urea (P = .025) after 2 weeks; however, the levels returned to ...

The oral solution is supplied in a 120 mL bottle containing 25 mg of sitagliptin per mL. Brynovin ™, an oral solution formulation of sitagliptin, is now available from Azurity Pharmaceuticals.

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)-- In a new post-hoc analysis presented for the first time at the American Diabetes Association (ADA) 70 th Annual Scientific Sessions, significantly more ...

Mumbai: Merck’s Januvia/Janumet (Sitagliptin) patent expiry has led to India's drug price regulator National Pharmaceutical Pricing Authority (NPPA) fixing the prices of fixed-dose combinations of ...